AARTIDRUGSAarti DrugsAARTIDRUGS info
$6.28info-0.88%24h
Global rank10571
Market cap$577.05M
Change 7d-7.04%
YTD Performance6.77%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Aarti Drugs (AARTIDRUGS) Stock Overview

    Aarti Drugs Limited, through its subsidiaries, engages in the manufacturing and marketing of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and formulations in India and internationally. The company provides APls in various therapeutic areas, including anti-inflammatory, cardioprotectants, antidiarrhoeals, antifungals, antiarthritis/osteoporosis, antibiotics, antidiabetics, Alzheimer's treatment, sedatives, vitamins, and alcoholism treatment; and pharmaceutical intermediate products comprising tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, nimesulide, and raloxifene. It also offers specialty chemical products, such as benzene sulphonyl chloride, benzene sulphonic acid, benzene sulphonic acid methyl ester, sodium benzene sulfinate, para toluene sulphonyl chloride, para toluene sulphonic acid methyl ester, N,N',N'-tris-(4-toluene sulfonyl)-diethylenetriamine, sodium para toluene sulfinate, para toluene sulphonyl hydrazide, di-phenyl sulphone, formamide, ammonium sulfate, and calcium fluoride, as well as benzene sulphonic acid sodium salt, benzyl nicotinate, methyl nicotinate, ethyl para toluene sulphonate, N-methyl methane sulfonamide, benzene sulphonamide, 2-phenoxy methane sulphanilide, para toluene sulfonamides, para chloro benzene sulphonamide, para chloro benzene sulphonyl chloride, ortho para toluene sulfonamides, ortho para toluene sulfonamides acid methyl ester, and N-methyl methane sulfonamides. In addition, the company's development products portfolio comprises Itraconazole and Fluconazole for antifungal applications; Dabigatran for use as an anticoagulant; Ticagrelor for cardiovascular diseases; Sitagliptin for use as an antidiabetics; and Alpha Lipoic Acid for application as an antioxidants. Further, it provides contract manufacturing services. Aarti Drugs Limited was incorporated in 1984 and is headquartered in Mumbai, India.

    AARTIDRUGS Stock Information

    Symbol
    AARTIDRUGS
    Address
    Mahendra Industrial EstateMumbai, 400 022India
    Founded
    -
    Trading hours
    -
    Website
    https://www.aartidrugs.co.in
    Country
    🇮🇳 India
    Phone Number
    91 22 2401 9025

    Aarti Drugs (AARTIDRUGS) Price Chart

    -
    Value:-

    Aarti Drugs Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $6.28
    N/A
    Market Cap
    $577.05M
    N/A
    Shares Outstanding
    91.94M
    N/A
    Employees
    1.00K
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org